Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 125 of 125 entries
Sorted by: Best Match Show Resources per page
Mixed matrix formulations with MOF molecular sieving for key energy-intensive separations.

Nature materials

Liu G, Chernikova V, Liu Y, Zhang K, Belmabkhout Y, Shekhah O, Zhang C, Yi S, Eddaoudi M, Koros WJ.
PMID: 29434309
Nat Mater. 2018 Mar;17(3):283-289. doi: 10.1038/s41563-017-0013-1. Epub 2018 Feb 12.

Membrane-based separations can improve energy efficiency and reduce the environmental impacts associated with traditional approaches. Nevertheless, many challenges must be overcome to design membranes that can replace conventional gas separation processes. Here, we report on the incorporation of engineered...

Cite
Liu G, Chernikova V, Liu Y, et al. Mixed matrix formulations with MOF molecular sieving for key energy-intensive separations. Nat Mater. 2018;17(3):283-289doi: 10.1038/s41563-017-0013-1.
Liu, G., Chernikova, V., Liu, Y., Zhang, K., Belmabkhout, Y., Shekhah, O., Zhang, C., Yi, S., Eddaoudi, M., & Koros, W. J. (2018). Mixed matrix formulations with MOF molecular sieving for key energy-intensive separations. Nature materials, 17(3), 283-289. https://doi.org/10.1038/s41563-017-0013-1
Liu, Gongping, et al. "Mixed matrix formulations with MOF molecular sieving for key energy-intensive separations." Nature materials vol. 17,3 (2018): 283-289. doi: https://doi.org/10.1038/s41563-017-0013-1
Liu G, Chernikova V, Liu Y, Zhang K, Belmabkhout Y, Shekhah O, Zhang C, Yi S, Eddaoudi M, Koros WJ. Mixed matrix formulations with MOF molecular sieving for key energy-intensive separations. Nat Mater. 2018 Mar;17(3):283-289. doi: 10.1038/s41563-017-0013-1. Epub 2018 Feb 12. PMID: 29434309.
Copy Download .nbib Format: NLM
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controls.

Pharmacotherapy

Stewart AW, Shillingburg A, Petros W, Wen S, Piktel D, Moses R, Gibson LF, Craig M, Cumpston A.
PMID: 34767652
Pharmacotherapy. 2021 Nov 12; doi: 10.1002/phar.2646. Epub 2021 Nov 12.

INTRODUCTION: Filgrastim is a human granulocyte colony-stimulating factor (G-CSF). There are limited data on dosing filgrastim in obesity. The objective of this study was to compare filgrastim pharmacokinetic parameters for morbidly obese and non-obese patients after a single subcutaneous...

Cite
Stewart AW, Shillingburg A, Petros W, et al. A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controls. Pharmacotherapy. 2021;doi: 10.1002/phar.2646.
Stewart, A. W., Shillingburg, A., Petros, W., Wen, S., Piktel, D., Moses, R., Gibson, L. F., Craig, M., & Cumpston, A. (2021). A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controls. Pharmacotherapy, . https://doi.org/10.1002/phar.2646
Stewart, Aaron W, et al. "A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controls." Pharmacotherapy vol. (2021). doi: https://doi.org/10.1002/phar.2646
Stewart AW, Shillingburg A, Petros W, Wen S, Piktel D, Moses R, Gibson LF, Craig M, Cumpston A. A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controls. Pharmacotherapy. 2021 Nov 12; doi: 10.1002/phar.2646. Epub 2021 Nov 12. PMID: 34767652.
Copy Download .nbib Format: NLM
Effect of ultra-processed foods consumption on glycemic control and gestational weight gain in pregnant with pregestational diabetes mellitus using carbohydrate counting.

PeerJ

Silva CFM, Saunders C, Peres W, Folino B, Kamel T, Dos Santos MS, Padilha P.
PMID: 33585080
PeerJ. 2021 Feb 01;9:e10514. doi: 10.7717/peerj.10514. eCollection 2021.

AIMS: The aims were to evaluate the consumption of ultra-processed foods by pregnant women with pre-existing diabetes mellitus (DM) using the carbohydrate counting method, in addition to investigating the association with total gestational weight gain and glycemic control.METHODS: A...

Cite
Silva CFM, Saunders C, Peres W, et al. Effect of ultra-processed foods consumption on glycemic control and gestational weight gain in pregnant with pregestational diabetes mellitus using carbohydrate counting. PeerJ. 2021;9:e10514doi: 10.7717/peerj.10514.
Silva, C. F. M., Saunders, C., Peres, W., Folino, B., Kamel, T., Dos Santos, M. S., & Padilha, P. (2021). Effect of ultra-processed foods consumption on glycemic control and gestational weight gain in pregnant with pregestational diabetes mellitus using carbohydrate counting. PeerJ, 9e10514. https://doi.org/10.7717/peerj.10514
Silva, Carolina F M, et al. "Effect of ultra-processed foods consumption on glycemic control and gestational weight gain in pregnant with pregestational diabetes mellitus using carbohydrate counting." PeerJ vol. 9 (2021): e10514. doi: https://doi.org/10.7717/peerj.10514
Silva CFM, Saunders C, Peres W, Folino B, Kamel T, Dos Santos MS, Padilha P. Effect of ultra-processed foods consumption on glycemic control and gestational weight gain in pregnant with pregestational diabetes mellitus using carbohydrate counting. PeerJ. 2021 Feb 01;9:e10514. doi: 10.7717/peerj.10514. eCollection 2021. PMID: 33585080; PMCID: PMC7860109.
Copy Download .nbib Format: NLM
Boyd Swinburn, the global syndemic and the NOVA classification.

Cadernos de saude publica

Peres J, Matioli V, Swindurn B.
PMID: 35019048
Cad Saude Publica. 2022 Jan 07;37:e00312520. doi: 10.1590/0102-311X00312520. eCollection 2022.

No abstract available.

Cite
Peres J, Matioli V, Swindurn B. Boyd Swinburn, a sindemia global e a classificação NOVA. Boyd Swinburn, the global syndemic and the NOVA classification. Cad Saude Publica. 2022;37:e00312520doi: 10.1590/0102-311X00312520.
Peres, J., Matioli, V., & Swindurn, B. (2022). Boyd Swinburn, a sindemia global e a classificação NOVA. Boyd Swinburn, the global syndemic and the NOVA classification. Cadernos de saude publica, 37e00312520. https://doi.org/10.1590/0102-311X00312520
Peres, João, et al. "Boyd Swinburn, a sindemia global e a classificação NOVA." Boyd Swinburn, the global syndemic and the NOVA classification. Cadernos de saude publica vol. 37 (2022): e00312520. doi: https://doi.org/10.1590/0102-311X00312520
Peres J, Matioli V, Swindurn B. Boyd Swinburn, a sindemia global e a classificação NOVA. Boyd Swinburn, the global syndemic and the NOVA classification. Cad Saude Publica. 2022 Jan 07;37:e00312520. doi: 10.1590/0102-311X00312520. eCollection 2022. Portuguese. PMID: 35019048.
Copy Download .nbib Format: NLM
Temporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain.

Cerebral cortex (New York, N.Y. : 1991)

Murillo A, Navarro AI, Puelles E, Zhang Y, Petros TJ, Pérez-Otaño I.
PMID: 33290502
Cereb Cortex. 2021 Mar 05;31(4):1914-1926. doi: 10.1093/cercor/bhaa330.

GluN3A subunits endow N-Methyl-D-Aspartate receptors (NMDARs) with unique biophysical, trafficking, and signaling properties. GluN3A-NMDARs are typically expressed during postnatal development, when they are thought to gate the refinement of neural circuits by inhibiting synapse maturation, and stabilization. Recent work...

Cite
Murillo A, Navarro AI, Puelles E, et al. Temporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain. Cereb Cortex. 2021;31(4):1914-1926doi: 10.1093/cercor/bhaa330.
Murillo, A., Navarro, A. I., Puelles, E., Zhang, Y., Petros, T. J., & Pérez-Otaño, I. (2021). Temporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain. Cerebral cortex (New York, N.Y. : 1991), 31(4), 1914-1926. https://doi.org/10.1093/cercor/bhaa330
Murillo, Alvaro, et al. "Temporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain." Cerebral cortex (New York, N.Y. : 1991) vol. 31,4 (2021): 1914-1926. doi: https://doi.org/10.1093/cercor/bhaa330
Murillo A, Navarro AI, Puelles E, Zhang Y, Petros TJ, Pérez-Otaño I. Temporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain. Cereb Cortex. 2021 Mar 05;31(4):1914-1926. doi: 10.1093/cercor/bhaa330. PMID: 33290502; PMCID: PMC7945027.
Copy Download .nbib Format: NLM
Showing 121 to 125 of 125 entries